The South America mammography market size was USD 87.04 Million in 2022 and is likely to reach USD 190.61 Million by 2031, expanding at a CAGR of 9.1% during 2023–2031. The growth of market is attributed to rising number of cases and research and development in the field of breast cancer, and technological enhancement in breast imaging modalities.
The increasing number of breast cancer incidences within the region is estimated to drive the market; the mortality rate caused by breast cancer is approximately 43,000 deaths annually in Latin America and Caribbean according to the Pan America Health Organization.
The growing number of cases in South America, owing to increased prevalence of hormonally-linked factors such as lifestyle risk factors along with late marriage and delay in child birth and low parity rate. Such conditions create a huge demand in the market for accurate and safer diagnosis of the disease.
New product development and innovative products are expected to boost the market during the projected period, the early technology of mammography includes 2D image of the breasts, which limits the accuracy quality. The flat nature of the images causes difficulties for the physicians to interpret the disease with utmost accuracy all because of overlapping of tissues and calcifications.
With the 3d technology already available in the picture know as digital breast tomosynthesis (DBT) allowing the physicians to obtain the 3D image of the breast and analyze it in depth and identify any abnormalities, and provide absolute conclusion on it, making the 2D technology an obsolete.
Due to COVID-19 outbreak market has witnessed lack of availability of screening services, and owing to lockdown procedure implemented by the government has created a disruption to some extent which has lower the demand for mammography, however physicians have reported increasing numbers of screening appointment since last year which is anticipated to drive the market.
Market Trends, Drivers, Restraints, and Opportunities
-
Increasing prevalence of breast cancer cases is estimated to boost the market during the forecast period.
-
Lack of awareness towards hormonal-linked factor being the cause of growing number of breast cancer cases is expected to drive the market during the projected period.
-
Increasing research activities in the field of breast cancer therapies is anticipated to propel the market during the forecast period.
-
Access to breast cancer screening system and government initiatives are some of the factors fuelling the market in the coming years.
-
Spreading awareness about breast cancer through healthcare programs is anticipated to ascend the market during the projected period.
-
R&D and technological advancement towards the new products for accurate interpretation of the diagnosed patient offers immense opportunities for the major players in the market.
Scope of South America Mammography Market
The report on South America mammography market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Mammography Market – South America Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Products (Digital System, Breast Tom synthesis, Film Screen Mammography Systems, Analog System, and Others), End-users (Specialty Clinics, Diagnostics Centers, and Hospitals)
|
|
Geographical Scope
|
Argentina, Brazil, Rest of South America
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
FujiFilms Corporations; Planmed Oy; GE Healthcare; Koninklijke Philips NV; Siemens Healthineers.
|
South America Mammography Market Segment Insights
The digital mammography system is expected to exhibit high CAGR
Based on the products, the market is segregated into digital system, breast tom synthesis, film screen mammography systems, analog system, and others. The digital mammography system is expected to exhibit high CAGR during the forecast period due to wider dynamic change, improved image quality especially when analyzed deeply, and excellent low-contrast object depiction and comparative to analog system the radiation exposure is extremely less it makes them more demandable within the segment.
The hospital segment is anticipated to constitute major share of the market
On the basis of end-users, the market is fragmented into specialty clinics, diagnostics centers, and hospitals. The hospital segment is anticipated to constitute major share of the market during the forecast period owing to early diagnosis of the patients suffering from the diseases and accordingly effective treatment and medication to reduce the possibility of cancer spread.
The diagnostics centers segment is expected to expand at steady pace owing to expensive price slabs and delay in report formation of the sufferer which increases the probability of cancer spread.
Segments
The South America mammography market has been segregated on the basis of
Products
- Digital System
- Breast Tom synthesis
- Film Screen Mammography Systems
- Analog System
- Others
End-users
- Specialty Clinics
- Diagnostics Centers
- Hospitals
Geographies
- Argentina
- Brazil
- Rest of South America
Key Players
Competitive Landscape
Key players competing in the South America mammography market include FujiFilms Corporations; Planmed Oy; GE Healthcare; Koninklijke Philips NV; Siemens Healthineers.
Some of these players are targeting on business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.
In July 2021, GE Healthcare announced installation of Serena Bright in 5 hospital and radiology centers in United States, Serena Bright industry’s first contrast guide biopsy solutions empowering patients fighting against breast cancer.
In November 2021, Siemens Healthineers announced FDA clearance two new mammography reading and workflow optimization solutions expanding the company’s offering for breast health.
In October 2021, FujiFilms Corporations announced that the ASPIRE Cristalle digital mammography system has received health Canada medical device license and also announced a strategic partnership with Christie Innomed to offer their services across the country.
Request For Customization
Enquiry Before Buying
Speak With Analyst
